FdaApplication
ANDA 205622
Identifiers
- fda_app_no: ANDA205622
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN TECHNOLOGIES INC |
| application_type | ANDA |
| approval_date | 2018-06-20 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIVASTIGMINE | RIVASTIGMINE | 9.5MG/24HR | FILM, EXTENDED RELEASE;TRANSDERMAL |
| RIVASTIGMINE | RIVASTIGMINE | 4.6MG/24HR | FILM, EXTENDED RELEASE;TRANSDERMAL |
| RIVASTIGMINE | RIVASTIGMINE | 13.3MG/24HR | FILM, EXTENDED RELEASE;TRANSDERMAL |
3 products